sunitinib glenmark 37,5 mg tvrdé kapsuly
glenmark pharmaceuticals s.r.o., Česká republika - sunitinib - 44 - cytostatica
sunitinib glenmark 25 mg tvrdé kapsuly
glenmark pharmaceuticals s.r.o., Česká republika - sunitinib - 44 - cytostatica
sunitinib glenmark 12,5 mg tvrdé kapsuly
glenmark pharmaceuticals s.r.o., Česká republika - sunitinib - 44 - cytostatica
firmagon
ferring pharmaceuticals a/s - degarelix - prostatické nádory - endokrinná terapia - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
clostilbegyt
egis pharmaceuticals plc, maďarsko - klomifén - 54 - gynaecologica
lucetam 400 mg
egis pharmaceuticals plc, maďarsko - piracetam - 06 - psychostimulantia (nootropne lieČ., analeptika)
lucetam 1200 mg
egis pharmaceuticals plc, maďarsko - piracetam - 06 - psychostimulantia (nootropne lieČ., analeptika)
foster nexthaler 200/6 mikrogramov/dávka
chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica
hydrocortisone medochemie 100 mg
medochemie ltd., cyprus - hydrokortizón - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
foster nexthaler 200/12 mikrogramov/dávka
chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica